Regional Medical Director - Skin/IO
Location: Remote with ~40% domestic and international travel
Shape the future of cancer care as a Medical Director, Skin/IO at Natera . In this strategic leadership role, you will provide medical expertise and scientific leadership across Natera โs oncology portfolio, with a focus on melanoma, cutaneous malignancies, and immunotherapy applications across solid tumors. You will collaborate with cross-functional teams in research, development, medical affairs, and commercial functions to ensure the scientific integrity and clinical adoption of Natera โs oncology testing solutions.
Primary Responsibilities:
Clinical Adoption:
- Lead the clinical strategy and evidence generation for melanoma, non-melanoma skin cancers, and pan-tumor immunotherapy indications.
- Partner closely with clinical development, medical affairs, and commercial teams to translate emerging evidence into meaningful clinical practice applications.
- Collaborate with key opinion leaders (KOLs), cooperative groups, and academic investigators to validate and expand clinical use cases for ctDNA-based diagnostics in immuno-oncology.
- Provide field-facing education and strategic guidance to healthcare providers, payers, and advocacy organizations on clinical utility, interpretation, and impact of MRD and response monitoring in immune-treated populations.
- Identify and address barriers to adoption by aligning evidence generation, messaging, and stakeholder engagement with evolving standards of care and health system needs.
Medical Education and Communication:
- Serve as the medical and scientific spokesperson for skin and immuno-oncology programs, communicating clinical utility, study data, and product value to external experts and stakeholders.
- Partner with commercial teams to develop educational resources, medical content, and scientific training for healthcare providers and internal teams.
- Provide scientific leadership during advisory boards, symposia, and investigator meetings.
Representation and Advocacy:
- Represent Natera at national and international oncology and immunotherapy conferences, fostering relationships with key opinion leaders in melanoma and IO.
- Promote a culture of scientific rigor and innovation within the medical affairs and R&D organizations.
Research and Development:
- Collaborate on clinical trial design, data analysis, and publication strategy related to ctDNA applications in melanoma and other immune-responsive solid tumors.
- Identify and cultivate academic and cooperative group partnerships to advance clinical validation and translational research in skin and pan-tumor immuno-oncology.
Key Skill Sets / Responsibilities:
Skin and Immuno-Oncology Expertise:
- Deep clinical knowledge of melanoma and cutaneous oncology, including evolving standards of care, targeted therapy, and checkpoint inhibitor use.
- Expertise in immunotherapy mechanisms, response kinetics, and biomarker development across multiple solid tumor types.
- Provide expert medical guidance on immunotherapy-specific diagnostic development and clinical implementation.
Comprehensive Oncology Knowledge:
- Ability to engage across tumor types to support Natera โs broad oncology portfolio.
- Maintain awareness of emerging trends in liquid biopsy, precision medicine, and immune response monitoring.
Cross-Disciplinary Collaboration:
- Work collaboratively with research, development, commercial, and medical affairs to align medical strategy with business objectives.
- Partner with regulatory and clinical operations teams to ensure compliance, data quality, and clinical relevance.
Qualifications:
- MD. or D.O. degree with board certification in Medical Oncology (required).
- At least 5 years of experience in oncology, with clinical or research experience in melanoma, skin cancers, or immunotherapy (preferred).
- Strong publication or clinical trial background in immuno-oncology or translational oncology research (preferred).
- Associ